Clinical Trial Update: A Study of Lemborexant in Chinese Participants With Insomnia Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of lemborexant for insomnia disorder in Chinese participants has completed, with results posted. The study assesses sleep initiation and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED | Results posted: 2024-12-20